Results 131 to 140 of about 140,892 (196)

Skin manifestations in diabetes-what is new? [PDF]

open access: yesFront Med (Lausanne)
Dorf N, Maciejczyk M.
europepmc   +1 more source

Evolução do consumo de retinóides desde 2000 a 2013 em Portugal. [PDF]

open access: yes, 2015
Maria Alexandra Leão de Magalhães Rodrigues
core  
Some of the next articles are maybe not open access.

Related searches:

Photoallergic Contact Dermatitis

Current Dermatology Reports, 2019
Photoallergic contact dermatitis (PACD) is a delayed-type hypersensitivity reaction to a photoactivated allergen applied to the skin. The purpose of this review is to provide comprehensive information about the mechanism of photoallergic contact dermatitis and to make an outline of its etiopathogenesis, clinical features, and treatment methods.
Aşkın, Özge   +3 more
openaire   +2 more sources

Allergic Contact Dermatitis, Photoallergic Contact Dermatitis, and Phototoxic Dermatitis

1981
Allergic eczematous contact dermatitis (ACD) is a disease of great clinical, scientific, and historical interest. This is in part due to the very characteristic changes in the epidermis and dermis evoked by this perhaps most uniquely “cutaneous” immunological response.
Rudolf L. Baer, David R. Bickers
openaire   +2 more sources

Perioral photoallergic dermatitis to promazine hydrochloride

Contact Dermatitis, 2022
Phenothiazines are well-known inducers of contact and photocontact sensitivity when utilized as topical antihistamines, while phototoxic reactions induced by their systemic use as antipsychotic drugs are rarely reported.
Paolo Romita   +7 more
openaire   +3 more sources

A new case of photoallergic contact dermatitis caused by benzophenones in magazine covers

Contact Dermatitis, 2022
Allergic contact dermatitis (ACD) and photoallergic contact dermatitis (PACD) to benzophenone present in printing ink have been reported. However, precise chemical analyses and extended photo‐patch tests have not been performed in these cases.
Q. Samaran   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy